Trial Profile
Clinical Trials Insight: 700044369
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2010
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions